Crystal forms of a HCV protease inhibitor
US9242917B2 · kind B2 · utility
0Cited by
3References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 2012 |
| Grant date | Jan 26, 2016 |
| Priority date | — |
| Expiry date | Aug 16, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to different forms of a HCV inhibitory compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.